Atlas Trials

Docosahexaenoic Acid (DHA) Supplementation in Amblyopia

Clinical trial NCT03402789 · WITHDRAWN

Trial details

NCT number
NCT03402789
Sponsor
Johns Hopkins University
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Amblyopia
Start date
2024-01-01
Primary completion
2024-07-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.